Abstract
Generalized anxiety disorder (GAD) is an emotional disorder characterized by excessive and difficult-to-control worry about daily events and activities such as work/school, finances, minor matters, community affairs, and health/safety. Despite initial concerns surrounding its diagnostic validity, a vast literature now exists on the nature, course, assessment, and treatment of GAD. This chapter reviews the current state of the science of GAD. GAD is one of the most common forms of psychopathology, resulting in significant human and economic burden across the world. It is partly heritable, and a selective number of serotonergic and catecholaminergic genetic markers have been identified in recent years, albeit with small individual effects. Neuroimaging and neurophysiological studies of GAD also have identified abnormalities in structure, functional connectivity (e.g., between the amygdala and dorsolateral prefrontal cortex), and event-related potentials (e.g., error-related negativity). In addition, several psychological (e.g., intolerance of uncertainty) and environmental (e.g., stress, childhood adversity) factors have been linked to GAD onset, expression, and course. Research on the psychopathology of GAD underscores the complex neurobiological–psychological profile of the condition. Nevertheless, significant progress has been made in the development of reliable assessment tools and effective treatments. Several self-report questionnaires and semistructured clinical interviews can be used to assess GAD. In addition, meta-analytic evidence suggests that serotonergic pharmacological agents and cognitive–behavioral therapy are first-line treatments. As understanding of GAD continues to improve, efforts are needed to develop personalized treatment recommendations based on intervention(s) predicted to achieve optimal benefit.
References
Abel, J. L., & Borkovec, T. D. (1995). Generalizability of DSM-III-R generalized anxiety disorder to proposed DSM-IV criteria and cross-validation of proposed changes. Journal of Anxiety Disorders, 9, 303–315.
Abelson, J. L., Glitz, D., Cameron, O. G., et al. (1991). Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Archives of General Psychiatry, 48, 157–162.
Alloy, L. C., & Clements, C. M. (1992). Illusion of control: Invulnerability to negative affect and depressive symptoms after laboratory and natural stressors. Journal of Abnormal Psychology, 101, 234–245.
American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed., DSM-III). American Psychiatric Press.
American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., Revised DSM-III-R). American Psychiatric Press.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed., DSM-IV). American Psychiatric Press.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Revision, DSM-IV-TR). American Psychiatric Press.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed., DSM-5). American Psychiatric Publishing.
Andrews, G., & Hobbs, M. J. (2010). The effect of the draft DSM-5 criteria for GAD on prevalence and severity. Australian and New Zealand Journal of Psychiatry, 44, 784–790.
Andrews, G., & Peters, L. (1998). The psychometric properties of the composite international diagnostic interview. Social Psychiatry and Psychiatric Epidemiology, 33, 80–88.
Andrews, G., Hobbs, M. J., Borkovec, T. D., et al. (2010). Generalized worry disorder: A review of DSM-IV generalized anxiety disorder and options for DSM-5. Depression and Anxiety, 27, 134–147.
Appel, H. B., Ai, A. L., Huang, B., et al. (2014). Detrimental effects of discrimination on mental health in Asian Americans: Counteracting roles of religious involvement. The International Journal for the Psychology of Religion, 24, 28–46.
Arch, J. J., Eifert, G. H., Davies, C., et al. (2012). Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders. Journal of Consulting and Clinical Psychology, 80, 750–765.
Baldwin, D., Woods, R., Lawson, R., et al. (2011). Efficacy of drug treatments for generalized anxiety disorder: Systematic review and meta-analysis. BMJ, 342, 1–11.
Ballenger, J. C., Davidson, J. R. T., Lecrubier, Y., et al. (2001). Consensus statement on generalized anxiety disorder from the international consensus group on anxiety and depression. Journal of Clinical Psychiatry, 62, 53–58.
Bandoli, G., Campbell-Sills, L., Kessler, R. C., et al. (2017). Childhood adversity, adult stress, and the risk of major depression or generalized anxiety disorder in US soldiers: A test of the stress sensitization hypothesis. Psychological Medicine, 47, 2379–2392.
Barlow, D. H. (2002). The nature of anxious apprehension. In D. H. Barlow (Ed.), Anxiety and its disorders (2nd ed.). Guilford Press.
Barlow, D. H., Blanchard, E. B., Vermilyea, J. A., et al. (1986). Generalized anxiety disorder: Description and reconceptualization. American Journal of Psychiatry, 143, 40–44.
Barlow, D. H., Rapee, R. M., & Brown, T. A. (1992). Behavioral treatment of generalized anxiety disorder. Behavior Therapy, 23, 551–570.
Barlow, D. H., Farchione, T. J., Bullis, J. R., et al. (2017). The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders: A randomized clinical trial. JAMA Psychiatry, 74, 875–884.
Barrett, P. M., Dadds, M. R., & Rapee, R. M. (1996). Family treatment of childhood anxiety: A controlled trial. Journal of Consulting and Clinical Psychology, 64, 333–342.
Beck, A. T., Emery, G., & Greenberg, R. L. (1985). Anxiety disorders and phobias: A cognitive perspective. Basic Books.
Beesdo, K., Hoyer, J., Jacobi, F., et al. (2009). Association between generalized anxiety levels and pain in a community sample: Evidence for diagnostic specificity. Journal of Anxiety Disorders, 23, 684–693.
Beidel, D. C., Silverman, W., & Hammond-Laurence, K. (1996). Overanxious disorder: Subsyndromal state or specific disorder? A comparison of clinic and community samples. Journal of Clinical Child Psychology, 25, 25–32.
Bernstein, D. A., & Borkovec, T. D. (1973). Progressive relaxation training: A manual for helping professions. Research Press.
Bienvenu, O. J., Hettema, J. M., Neale, M. C., et al. (2007). Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. American Journal of Psychiatry, 164, 1714–1721.
Blanchard, E. B., Scharff, L., Schwarz, S. P., et al. (1990). The role of anxiety and depression in the irritable bowel syndrome. Behaviour Research and Therapy, 28, 401–405.
Bomyea, J., Ramsawh, H., Ball, T. M., et al. (2015). Intolerance of uncertainty as a mediator of reductions in worry in a cognitive behavioral treatment program for generalized anxiety disorder. Journal of Anxiety Disorders, 33, 90–94.
Borkovec, T. D. (1994). The nature, functions, and origins of worry. In G. C. L. Davey & F. Tallis (Eds.), Worrying: Perspectives on theory, assessment, and treatment. Wiley.
Borkovec, T. D., & Costello, E. (1993). Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 61, 611–619.
Borkovec, T. D., & Hu, S. (1990). The effect of worry on cardiovascular response to phobic imagery. Behaviour Research and Therapy, 28, 69–73.
Borkovec, T. D., & Mathews, A. M. (1988). Treatment of non-phobic anxiety disorders: A comparison of nondirective, cognitive, and coping desensitization therapy. Journal of Consulting and Clinical Psychology, 56, 877–884.
Borkovec, T. D., & Roemer, L. (1995). Perceived functions of worry among generalized anxiety disorder subjects: Distraction from more emotionally distressing topics? Journal of Behavior Therapy and Experimental Psychiatry, 26, 25–30.
Borkovec, T. D., Abel, J. L., & Newman, H. (1995). Effects of psychotherapy on comorbid conditions in generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 63, 479–483.
Borkovec, T. D., Hazlett-Stevens, H., & Diaz, M. L. (1999). The role of positive beliefs about worry in generalized anxiety disorder and its treatment. Clinical Psychology and Psychotherapy, 6, 126–138.
Borkovec, T. D., Newman, M. G., Pincus, A. L., et al. (2002). A component analysis of cognitive-behavioral therapy for generalized anxiety disorder and the role of interpersonal problems. Journal of Consulting and Clinical Psychology, 70, 288–298.
Boschen, M. J. (2011). Generalized anxiety disorder in adults: Focus on pregabalin. Clinical Medicine Insights: Psychiatry, 4, 17–35.
Brawman-Mintzer, O., Lydiard, R. B., Crawford, M. M., et al. (1994). Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders. American Journal of Psychiatry, 150, 1216–1218.
Brenes, G. A., Knudson, M., McCall, W. V., Williamson, J. D., Miller, M. E., & Stanley, M. A. (2008). Age and racial differences in the presentation and treatment of generalized anxiety disorder in primary care. Journal of Anxiety Disorders, 22(7), 1128–1136.
Breslau, N., & Davis, G. C. (1985). Further evidence of the doubtful validity of generalized anxiety disorder. Psychiatry Research, 16, 177–179.
Brown, T. A., & Barlow, D. H. (2005). Dimensional versus categorical classification of mental disorders in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders and beyond: Comment on the special section. Journal of Abnormal Psychology, 114, 551–556.
Brown, T. A., & Barlow, D. H. (2014). Anxiety and related disorders interview schedule for DSM-5: Lifetime version (ADIS-5L). Oxford University Press.
Brown, T. A., & Naragon-Gainey, K. (2013). Evaluation of the unique and specific contributions of dimensions of the triple vulnerability model to the prediction of DSM-IV anxiety and mood disorder constructs. Behavior Therapy, 44, 277–292.
Brown, T. A., & Tung, E. S. (2018). The contribution of worry behaviors to the diagnosis of generalized anxiety disorder. Journal of Psychopathology and Behavioral Assessment, 40, 636–644.
Brown, T. A., Antony, M. M., & Barlow, D. H. (1992). Psychometric properties of the Penn State Worry Questionnaire in a clinical anxiety disorders sample. Behaviour Research and Therapy, 30, 33–38.
Brown, T. A., Moras, K., Zinbarg, R. E., et al. (1993). Diagnostic and symptom distinguishability of generalized anxiety disorder and obsessive–compulsive disorder. Behaviour Research and Therapy, 24, 227–240.
Brown, T. A., Marten, P. A., & Barlow, D. H. (1995). Discriminant validity of the symptoms constituting the DSM-III-R and DSM-IV associated symptoms criterion of generalized anxiety disorder. Journal of Anxiety Disorders, 9, 317–328.
Brown, T. A., Chorpita, B. F., & Barlow, D. H. (1998). Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. Journal of Abnormal Psychology, 107, 179–192.
Brown, T. A., Campbell, L. A., Lehman, C. L., et al. (2001a). Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. Journal of Abnormal Psychology, 110, 585–599.
Brown, T. A., Di Nardo, P. A., Lehman, C. L., et al. (2001b). Reliability of DSM-IV anxiety and mood disorders: Implications for classification of emotional disorders. Journal of Abnormal Psychology, 110, 49–58.
Bruce, S. E., Yonkers, K. A., Otto, M. W., et al. (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. American Journal of Psychiatry, 162, 1179–1187.
Buhr, K., & Dugas, M. J. (2002). The intolerance of uncertainty scale: Psychometric properties of the English version. Behaviour Research and Therapy, 40, 931–946.
Burkhouse, K. L., Woody, M. L., Owens, M., et al. (2015). Influence of worry on sustained attention to emotional stimuli: Evidence from the late positive potential. Neuroscience Letters, 588, 57–61.
Campbell, L. A., Brown, T. A., & Grisham, J. R. (2003). The relevance of age of onset to the psychopathology of generalized anxiety disorder. Behavior Therapy, 34, 31–48.
Carl, E., Witcraft, S. M., Kauffman, B. Y., et al. (2020). Psychological and pharmacological treatments for generalized anxiety disorder (GAD): A meta-analysis of randomized controlled trials. Cognitive Behaviour Therapy, 49, 1–21.
Chambers, J. A., Power, K. G., & Durham, R. C. (2004). The relationship between trait vulnerability and anxiety and depressive diagnoses at long-term follow-up of generalized anxiety disorder. Journal of Anxiety Disorders, 18, 587–607.
Chmielewski, M., Clark, L. A., Bagby, R. M., et al. (2015). Method matters: Understanding diagnostic reliability in DSM-IV and DSM-5. Journal of Abnormal Psychology, 124, 764–769.
Clark, T. T., Salas-Wright, C. P., Vaughn, M. G., et al. (2015). Everyday discrimination and mood and substance use disorders: A latent profile analysis with African Americans and Caribbean blacks. Addictive Behaviors, 40, 119–125.
Cole, D. A., & Turner, J. E. (1993). Models of cognitive mediation and moderation in child depression. Journal of Abnormal Psychology, 102, 271–281.
Coles, M. E., Mennin, D. S., & Heimberg, R. G. (2001). Distinguishing obsessive features and worries: The role of thought–action fusion. Behaviour Research and Therapy, 39, 947–959.
Comer, J. S., Pincus, D. B., & Hofmann, S. G. (2012). Generalized anxiety disorder and the proposed associated symptoms criterion change for DSM-5 in a treatment-seeking sample of anxious youth. Depression and Anxiety, 29, 994–1003.
Covin, R., Ouimet, A. J., Seeds, P. M., et al. (2008). A meta-analysis of CBT for pathological worry among clients with GAD. Journal of Anxiety Disorders, 22, 108–116.
Craske, M. G., Rapee, R. M., Jackel, L., et al. (1989). Qualitative dimensions of worry in DSM-III-R generalized anxiety disorder subjects and nonanxious controls. Behaviour Research and Therapy, 27, 397–402.
Craske, M. G., Barlow, D. H., & Meadows, E. (2000). Mastery of your anxiety and worry. Oxford University Press.
Crits-Cristoph, P., Newman, M. G., Rickels, K., et al. (2011). Combined medication and cognitive therapy for generalized anxiety disorder. Journal of Anxiety Disorders, 25, 1087–1094.
Cuijpers, P., Sijbrandij, M., Koole, S., et al. (2014). Psychological treatment of generalized anxiety disorder: A meta-analysis. Clinical Psychology Review, 34, 130–140.
Davidson, J. R., DuPont, R. L., Hedges, D., et al. (1999). Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. Journal of Clinical Psychiatry, 60, 528–535.
DeBellis, M. D., Casey, B. J., Dahl, R. E., et al. (2000). A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biological Psychiatry, 48, 51–57.
Denicoff, K. D., Joffe, R. T., Lakshmanan, M. C., et al. (1990). Neuropsychiatric manifestations of altered thyroid state. American Journal of Psychiatry, 147, 94–99.
Di Nardo, P. A., Moras, K., Barlow, D. H., et al. (1993). Reliability of DSM-III-R anxiety disorder categories. Using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Archives of General Psychiatry, 50, 251–256.
Di Nardo, P. A., Brown, T. A., & Barlow, D. H. (1994). Anxiety disorders interview schedule for DSM-IV: Lifetime version (ADIS-IV-L). Oxford University Press.
Diefenbach, G. J., Stanley, M. A., & Beck, J. G. (2001). Worry content reported by older adults with and without generalized anxiety disorder. Aging and Mental Health, 5, 269–274.
Diefenbach, G. J., Hopko, D. R., Feigon, S., et al. (2003). “Minor GAD”: Characteristics of subsyndromal GAD in older adults. Behaviour Research and Therapy, 41, 481–487.
Dugas, M. J., Gagnon, F., Ladouceur, R., et al. (1998). Generalized anxiety disorder: A preliminary test of a conceptual model. Behaviour Research and Therapy, 36, 215–226.
Dugas, M. J., Marchand, A., & Ladouceur, R. (2005). Further validation of a cognitive-behavioral model of generalized anxiety disorder: Diagnostic and symptom specificity. Journal of Anxiety Disorders, 19, 329–343.
Dunn, E. C., Sofer, T., Gallo, L. C., et al. (2017). Genome-wide association study of generalized anxiety symptoms in the Hispanic Community Health Study/Study of Latinos. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 174, 132–143.
Durgam, S., Gommoll, C., Forero, G., et al. (2016). Efficacy and safety of vilazodone in patients with generalized anxiety disorder: A randomized, double-blind, placebo-controlled, flexible-dose trial. Journal of Clinical Psychiatry, 77, 1687–1694.
Dyck, I. R., Phillips, K. A., Warshaw, M. G., et al. (2001). Patterns of personality pathology in patients with generalized anxiety disorder, panic disorder with and without agoraphobia, and social phobia. Journal of Personality Disorders, 15, 60–71.
Eisen, A. R., & Silverman, W. K. (1998). Prescriptive treatment for generalized anxiety disorder in children. Behavior Therapy, 29, 105–121.
First, M. B., Williams, J. B., Karg, R. S., et al. (2015). Structured clinical interview for DSM-5 disorders, clinician version (SCID-5-CV). American Psychiatric Association.
Fisher, A. J., & Newman, M. G. (2013). Heart rate and autonomic response to stress after experimental induction of worry versus relaxation in healthy, high-worry, and generalized anxiety disorder individuals. Biological Psychology, 93, 65–74.
Flannery-Schroeder, E. C., & Kendall, P. C. (2000). Group and individual cognitive-behavioral treatments for youth with anxiety disorders: A randomized clinical trial. Cognitive Therapy and Research, 24, 251–278.
Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99, 20–35.
Francis, J. L., Moitra, E., Dyck, I., et al. (2012). The impact of stressful life events on relapse of generalized anxiety disorder. Depression and Anxiety, 29, 386–391.
Friedman, B. H., & Thayer, J. F. (1998). Autonomic balance revisited: Panic anxiety and heart rate variability. Journal of Psychosomatic Research, 44, 133–151.
Gambi, F., De Berardis, D., Campanella, D., et al. (2005). Mirtazapine treatment of generalized anxiety disorder: A fixed dose, open label study. Journal of Psychopharmacology, 19, 483–487.
Gammans, R. E., Stringfellow, J. C., Hvizdos, A. J., et al. (1992). Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms: A meta-analysis of eight randomized, controlled trials. Neuropsychobiology, 25, 193–201.
Gelenberg, A. J., Lydiard, R. B., Rudolph, R. L., et al. (2000). Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder. JAMA, 283, 3082–3088.
Gentes, E. L., & Ruscio, A. M. (2011). A meta-analysis of the relation of intolerance of uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and obsessive–compulsive disorder. Clinical Psychology Review, 31, 923–933.
Germine, M., Goddard, A. W., Woods, S. W., et al. (1992). Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder. Biological Psychiatry, 32, 457–461.
Goncalves, D. C., & Byrne, G. J. (2012). Interventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis. Journal of Anxiety Disorders, 26, 1–11.
Goodman, W. K., Bose, A., & Wang, Q. (2005). Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trials. Journal of Affective Disorders, 87, 161–167.
Gordon, D., & Heimberg, R. G. (2011). Reliability and validity of DSM-IV generalized anxiety disorder features. Journal of Anxiety Disorders, 25, 813–821.
Gorka, S. M., Katie, L., Burkhouse, K. A., & Luan Phan, K. (2017). Error-related brain activity and internalizing disorder symptom dimensions in depression and anxiety. Depression and Anxiety, 34, 985–995.
Gottschalk, M. G., & Domschke, K. (2017). Genetics of generalized anxiety disorder and related traits. Dialogues in Clinical Neuroscience, 19, 159–168.
Grant, B. F., Stinson, F. S., Dawson, D. A., et al. (2004). Prevalence and co-occurrence of substance abuse disorders and independent mood and anxiety disorders. Archives of General Psychiatry, 61, 807–816.
Grant, B. F., Hasin, D. S., Stinson, F. S., et al. (2005a). Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the US: Results from the National Epidemiologic Survey on alcohol and related conditions. Psychological Medicine, 35, 1747–1759.
Grant, B. F., Hasin, D. S., Stinson, F. S., et al. (2005b). Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: Results from the national epidemiologic survey on alcohol and related conditions. Journal of Psychiatric Research, 39, 1–9.
Greer, S., Ramsay, I., & Bagley, C. (1973). Neurotic and thyrotoxic anxiety: Clinical, psychological and physiological measurements. British Journal of Psychiatry, 122, 549–554.
Hall, J., Kellett, S., Berrios, R., et al. (2016). Efficacy of cognitive behavioral therapy for generalized anxiety disorder in older adults: Systematic review, meta-analysis, and meta-regression. The American Journal of Geriatric Psychiatry, 24, 1063–1073.
Haller, H., Cramer, H., Lauche, R., et al. (2014). The prevalence and burden of subthreshold generalized anxiety disorder: A systematic review. BMC Psychiatry, 14, 128.
Hallion, L. S., & Ruscio, A. M. (2013). Should uncontrollable worry be removed from the definition of GAD? A test of incremental validity. Journal of Abnormal Psychology, 122, 369–375.
Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50–55.
Hamilton, S. P. (2009). Linkage and association studies of anxiety disorders. Depression and Anxiety, 26, 976–983.
Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and commitment therapy: An experiential approach to behavior change. Guilford Press.
Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (2011). Acceptance and commitment therapy: The process and practice of mindful change (2nd ed.). Guilford Press.
Hayes-Skelton, S. A., Orsillo, S. M., & Roemer, L. (2013). An acceptance-based behavioral therapy for individuals with generalized anxiety disorder. Cognitive and Behavioral Practice, 20(3), 264–281.
Hazlett, R. L., McLeod, D. R., & Hoehn-Saric, R. (1994). Muscle tension in generalized anxiety disorder: Elevated muscle tonus or agitated movement? Psychophysiology, 31, 189–195.
Hettema, J. M., Neale, M. C., & Kendler, K. S. (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. Archives of General Psychiatry, 158, 1568–1578.
Hettema, J. M., Prescott, C. A., & Kendler, K. S. (2004). Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Archives of General Psychiatry, 161, 1581–1587.
Hettema, J. M., Prescott, C. A., Myers, J. M., et al. (2005). The structure of genetic and environmental risk factors for anxiety disorders in men and women. Archives of General Psychiatry, 62, 182–188.
Hettema, J. M., Neale, M. C., Myers, J. M., et al. (2006). A population-based twin study of the relationship between neuroticism and internalizing disorders. American Journal of Psychiatry, 163, 857–864.
Hettema, J. M., Verhulst, B., Chatzinakos, C., et al. (2020). Genome-wide association study of shared liability to anxiety disorders in Army STARRS. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 183, 197–207.
Himmelfarb, S., & Murrell, S. A. (1984). The prevalence and correlates of anxiety symptoms in older adults. Journal of Psychology, 116, 159–167.
Hinton, D. E., Nickerson, A., & Bryant, R. A. (2011). Worry, worry attacks, and PTSD among Cambodian refugees: A path analysis investigation. Social Science & Medicine, 72, 1817–1825.
Hirschtritt, M. E., Olfson, M., & Kroenke, K. (2021). Balancing the risks and benefits of benzodiazepines. JAMA, 325, 347–348.
Hoehn-Saric, R., McLeod, D. R., & Zimmerli, W. D. (1988). Differential effects of alprazolam and imipramine in generalized anxiety disorder: Somatic versus psychic complaints. Journal of Clinical Psychiatry, 49, 293–301.
Hoehn-Saric, R., McLeod, D. R., & Zimmerli, W. D. (1989). Somatic manifestations in women with generalized anxiety disorder. Psychophysiological responses to psychological stress. Archives of General Psychiatry, 46, 1113–1119.
Hoehn-Saric, R., McLeod, D. R., Funderburk, F., et al. (2004). Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder. Archives of General Psychiatry, 61, 913–921.
Hoffman, D. L., Dukes, E. M., & Wittchen, H. U. (2008). Human and economic burden of generalized anxiety disorder. Depression and Anxiety, 25, 72–90.
Hoge, E. A., Tamrakar, S. M., & Christian, K. M. (2006). Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder. Journal of Nervous and Mental Disease, 194, 962–966.
Hoppen, T. H., & Chalder, T. (2018). Childhood adversity as a transdiagnostic risk factor for affective disorders in adulthood: A systematic review focusing on biopsychosocial moderating and mediating variables. Clinical Psychology Review, 65, 81–151.
Joormann, J., & Stöber, J. (1999). Somatic symptoms of generalized anxiety disorder for the DSM-IV: Associations with pathological worry and depression symptoms in a nonclinical sample. Journal of Anxiety Disorders, 13, 491–503.
Kane, M. T., & Kendall, P. C. (1989). Anxiety disorders in children: A multiple-baseline evaluation of a cognitive-behavioral treatment. Behavior Therapy, 20, 499–508.
Kelly, C. B., & Cooper, S. J. (1998). Differences and variability in plasma noradrenaline between depressive and anxiety disorders. Journal of Psychopharmacology, 12, 161–167.
Kendall, P. C. (1994). Treating anxiety disorders in children: Results of a randomized clinical trial. Journal of Consulting and Clinical Psychology, 62, 100–110.
Kendall, P. C., Flannery-Schroeder, E., Panichelli-Mindel, S. M., et al. (1997). Therapy for youths with anxiety disorders: A second randomized clinical trial. Journal of Consulting and Clinical Psychology, 65, 366–380.
Kendler, K. S., Neale, M. C., Kessler, R. C., et al. (1992). Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Archives of General Psychiatry, 49, 716–722.
Kessler, R. C., Abelson, J., Demler, O., et al. (2004). Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) composite international diagnostic interview (WMHCIDI). International Journal of Methods in Psychiatric Research, 13, 122–139.
Kessler, R. C., Berglund, P., Demler, O., et al. (2005a). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593–602.
Kessler, R. C., Chiu, W. T., Demler, O., et al. (2005b). Prevalence, severity, comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627.
Kessler, R. C., Brandenburg, N., Lane, M., et al. (2006). Rethinking the duration requirement for generalized anxiety disorder: Evidence from the National Comorbidity Survey Replication. Psychological Medicine, 35, 1073–1082.
Kolesar, T. A., Bilevicius, E., Wilson, A. D., et al. (2019). Systematic review and meta-analyses of neural structural and functional differences in generalized anxiety disorder and healthy controls using magnetic resonance imaging. NeuroImage: Clinical, 24, 102016.
Kubarych, T. S., Aggen, S. H., Hettema, J. M., et al. (2005). Endorsement frequencies and factor structure of DSM-III-R and DSM-IV generalized anxiety disorder symptoms in women: Implications for future research, classification, clinical practice, and comorbidity. International Journal of Methods in Psychiatric Research, 14, 69–81.
Lader, M. H., & Bond, A. J. (1998). Interaction of pharmacological and psychological treatments of anxiety. British Journal of Psychiatry, 17, 42–48.
Ladouceur, R., Blais, F., Freeston, M. H., et al. (1998). Problem solving and problem orientation in generalized anxiety disorder. Journal of Anxiety Disorders, 12, 139–152.
Ladouceur, R., Dugas, M. J., Freeston, M. H., et al. (1999). Specificity of generalized anxiety disorder symptoms and processes. Behavior Therapy, 30, 191–207.
Ladouceur, R., Dugas, M. J., Freeston, M. H., et al. (2000). Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: Evaluation in a controlled clinical trial. Journal of Consulting and Clinical Psychology, 68, 957–964.
Langlois, F., Freeston, M. H., & Ladouceur, R. (2000). Differences and similarities between obsessive intrusive thoughts and worry in a non-clinical population: Study 1. Behaviour Research and Therapy, 38, 157–173.
Lawrence, A. E., Liverant, G. I., Rosellini, A. J., et al. (2009). Generalized anxiety disorder within the course of major depressive disorder: Examining the utility of the DSM-IV hierarchy rule. Depression and Anxiety, 26, 909–916.
Lee, S., Tsang, A., Chui, H., Kwok, K., & Cheung, E. (2007). A community epidemiological survey of generalized anxiety disorder in Hong Kong. Community Mental Health Journal, 43, 305–319.
Lee, S., Wu, J., Ma, Y. L., et al. (2009). Irritable bowel syndrome is strongly associated with generalized anxiety disorder: A community study. Alimentary Pharmacology & Therapeutics, 30, 643–651.
Litwin, H., & Meir, A. (2013). Financial worry among older people: Who worries and why? Journal of Aging Studies, 27, 113–120.
Lovibond, P. F., & Lovibond, S. H. (1995). The structure of negative emotional states: Comparison of the depression anxiety stress scales (DASS) with the Beck depression and anxiety inventories. Behaviour Research and Therapy, 33, 335–343.
Mahoney, A. E., Hobbs, M. J., Newby, J. M., et al. (2016). The worry behaviors inventory: Assessing behavioral avoidance associated with generalized anxiety disorder. Journal of Affective Disorders, 203, 256–264.
Marcus, S. C., Olfson, M., Pincus, H. A., et al. (1997). Self-reported anxiety, general medical conditions, and disability bed days. American Journal of Psychiatry, 154, 1766–1768.
Marques, L., Robinaugh, D. J., LeBlanc, N. J., & Hinton, D. (2011). Cross-cultural variations in the prevalence and presentation of anxiety disorders. Expert Review of Neurotherapeutics, 11(2), 313–322.
Marten, P. A., Brown, T. A., Barlow, D. H., et al. (1993). Evaluation of the ratings compromising the associated symptoms criterion of DSM-III-R generalized anxiety disorder. Journal of Nervous and Mental Disease, 181, 676–682.
Martens, E. J., de Jonge, P., Na, B., et al. (2010). Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: The heart and soul study. Archives of General Psychiatry, 67, 750–758.
Massion, A. O., Dyck, I. R., Shea, M. T., et al. (2002). Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder. Archives of General Psychiatry, 59, 434–440.
Mathew, R. J., Ho, B. T., & Taylor, D. T. (1982). Dopamine beta-hydroxylase response to epinephrine injection in anxious patients and normals. Biological Psychiatry, 17, 393–397.
McClure, E. B., Monk, C. S., Nelson, E. E., et al. (2007). Abnormal attentional modulation of fear circuit function in pediatric generalized anxiety disorder. Archives of General Psychiatry, 64, 97–106.
McEvoy, P. M., & Mahoney, A. E. (2012). To be sure, to be sure: Intolerance of uncertainty mediates symptoms of various anxiety disorders and depression. Behavior Therapy, 43, 533–545.
McLaughlin, K. A., Conron, K. J., Koenen, K. C., et al. (2010). Childhood adversity, adult stressful life events, and risk of past-year psychiatric disorder: A test of the stress sensitization hypothesis in a population-based sample of adults. Psychological Medicine, 40, 1647–1658.
Meichenbaum, D. S., & Jaremko, M. E. (Eds.). (1983). Stress reduction and prevention. Plenum Press.
Meyer, T. J., Miller, M. L., Metzger, R. L., et al. (1990). Development and validation of the Penn State Worry Questionnaire. Behaviour Research and Therapy, 28, 487–495.
Meyer, A., Hajcak, G., Torpey-Newman, D. C., et al. (2015). Enhanced error-related brain activity in children predicts the onset of anxiety disorders between the ages of 6 and 9. Journal of Abnormal Psychology, 124, 266–274.
Meyer, A., Nelson, B., Perlman, G., et al. (2018). A neural biomarker, the error-related negativity, predicts the first onset of generalized anxiety disorder in a large sample of adolescent females. Journal of Child Psychology and Psychiatry, 59, 1162–1170.
Miloyan, B., Bienvenu, O. J., Brilot, B., et al. (2018). Adverse life events and the onset of anxiety disorders. Psychiatry Research, 259, 488–492.
Mitte, K. (2005). Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: A comparison with pharmacotherapy. Psychological Bulletin, 131, 785–795.
Moras, K., Di Nardo, P. A., & Barlow, D. H. (1992). Distinguishing anxiety and depression: Reexamination of the reconstructed Hamilton scales. Psychological Assessment, 4, 224–227.
Muris, P., Merckelbach, H. M., Meesters, C., et al. (2002). Cognitive development and worry in normal children. Cognitive Therapy and Research, 26, 775–785.
Naragon-Gainey, K., Gallagher, M. W., & Brown, T. A. (2013). Stable “trait” variance of temperament as a predictor of the temporal course of depression and social phobia. Journal of Abnormal Psychology, 122, 611–623.
Newman, M. G., Zuellig, A. R., Kachin, K. E., et al. (2002). Preliminary reliability and validity of the GAD-Q-IV: A self-report diagnostic measure of generalized anxiety disorder. Behavior Therapy, 33, 215–233.
Oathes, D. J., Ray, W. J., Yamasaki, A. S., et al. (2008). Worry, generalized anxiety disorder, and emotion: Evidence from the EEG gamma band. Biological Psychology, 79, 165–170.
Olvet, D. M., & Hajcak, G. (2008). The error-related negativity (ERN) and psychopathology: Toward an endophenotype. Clinical Psychology Review, 28, 1343–1354.
Orsillo, S. M., Roemer, L., & Barlow, D. H. (2003). Integrating acceptance and mindfulness into existing cognitive-behavioral treatments for GAD. Cognitive and Behavioral Practice, 10, 222–230.
Osório, F. L., Loureiro, S. R., Hallak, J. E., et al. (2019). Clinical validity and intrarater and test–retest reliability of the Structured Clinical Interview for DSM-5–Clinician Version (SCID-5-CV). Psychiatry and Clinical Neurosciences, 73, 754–760.
Otowa, T., Hek, K., Lee, M., et al. (2016). Meta-analysis of genome-wide association studies of anxiety disorders. Molecular Psychiatry, 21, 1391–1399.
Pae, C.-U., Wang, S.-M., Han, C., et al. (2015). Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis. Journal of Psychiatric Research, 64, 88–98.
Pluess, M., Conrad, A., & Wilhelm, F. H. (2009). Muscle tension in generalized anxiety disorder: A critical review of the literature. Journal of Anxiety Disorders, 23, 1–11.
Power, K., Simpson, R., Swanson, V., et al. (1990). A controlled comparison of cognitive-behavior therapy, diazepam, and placebo, alone and in combination, for the treatment of generalized anxiety disorder. Journal of Anxiety Disorders, 4, 267–292.
Rachman, S. J. (1973). Some similarities and differences between obsessional ruminations and morbid preoccupations. Canadian Psychiatric Association Journal, 18, 71–74.
Rachman, S. J. (1993). Obsessions, responsibility and guilt. Behaviour Research and Therapy, 31, 149–154.
Rapee, R. M. (1991). Generalized anxiety disorder: A review of clinical features and theoretical concepts. Clinical Psychology Review, 11, 419–440.
Ray, W. J., Molnar, C., Aikins, D., et al. (2009). Startle response in generalized anxiety disorder. Depression and Anxiety, 26, 147–154.
Regier, D. A., Narrow, W. E., Clarke, D. E., et al. (2013). DSM-5 field trials in the United States and Canada, part II: Test–retest reliability of selected categorical diagnoses. American Journal of Psychiatry, 170, 59–70.
Rickels, K., Downing, R., Schweizer, E., et al. (1993). Antidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone, and diazepam. Archives of General Psychiatry, 50, 884–895.
Rickels, K., Zanielli, R., McCafferty, J., et al. (2003). Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study. American Journal of Psychiatry, 160, 749–756.
Rickels, K., Etemad, B., Khalid-Khan, S., et al. (2010). Time to relapse after 6 and 12 months’ treatment of generalized anxiety disorder with venlafaxine extended release. Archives of General Psychiatry, 67, 1274–1281.
Roemer, L., Molina, S., Litz, B. T., et al. (1996). Preliminary investigation of the role of previous exposure to potentially traumatizing events in generalized anxiety disorder. Depression and Anxiety, 4, 134–138.
Roemer, L., Orsillo, S. M., & Barlow, D. H. (2002). Generalized anxiety disorder. In D. H. Barlow (Ed.), Anxiety and its disorders (2nd ed.). Guilford Press.
Roest, A. M., Martens, E. J., de Jonge, P., et al. (2010). Anxiety and risk of incident coronary heart disease: A meta-analysis. Journal of the American College of Cardiology, 56, 38–46.
Ruscio, A. M., Lane, M., Roy-Byrne, P., et al. (2005). Should excessive worry be a requirement for a diagnosis of generalized anxiety disorder? Results from the National Comorbidity Survey Replication. Psychological Medicine, 35, 1761–1772.
Ruscio, A. M., Chiu, W. T., Roy-Byrne, P., et al. (2007). Broadening the definition of generalized anxiety disorder: Effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. Journal of Anxiety Disorders, 21, 662–676.
Ruscio, A. M., Hallion, L. S., Lim, C. C., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., … & Scott, K. M. (2017). Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe. JAMA Psychiatry, 74(5), 465–475.
Rutter, L. A., & Brown, T. A. (2015). Reliability and validity of the dimensional features of generalized anxiety disorder. Journal of Anxiety Disorders, 29, 1–6.
Rynn, M. A., Siqueland, L., & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. American Journal of Psychiatry, 158, 2008–2014.
Rynn, M. A., Riddle, M. A., Yeung, P. P., et al. (2007). Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: Two placebo-controlled trials. American Journal of Psychiatry, 164, 290–300.
Sanderson, W. C., & Barlow, D. H. (1990). A description of patients diagnosed with DSM-III-R generalized anxiety disorder. Journal of Nervous and Mental Disease, 178, 588–591.
Sanderson, W. C., & Wetzler, S. (1991). Chronic anxiety and generalized anxiety disorder: Issues in comorbidity. In R. M. Rapee & D. H. Barlow (Eds.), Chronic anxiety: Generalized anxiety disorder and mixed anxiety-depression. Guilford Press.
Sanderson, W. C., Wetzler, S., Beck, A. T., & Betz, F. (1994). Prevalence of personality disorders among patients with anxiety disorders. Psychiatry Research, 51, 167–174.
Sawa, A., Berenbaum, H., & Okazaki, S. (2013). Influences of personal standards and perceived parental expectations on worry for Asian American and white American college students. Anxiety, Stress, & Coping, 26, 187–202.
Schwartz, S. H., & Melech, G. (2000). National differences in micro and macros worry: Social, economic, and cultural explanations. In E. Diener & E. M. Suh (Eds.), Culture and subjective well-being (pp. 219–256). The MIT Press.
Scott, E. L., Eng, W., & Heimberg, R. G. (2002). Ethnic differences in worry in a nonclinical population. Depression and Anxiety, 15, 79–82.
Shankman, S. A., Funkhouser, C. J., Klein, D. N., et al. (2018). Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM-5 (SCID). International Journal of Methods in Psychiatric Research, 27, e1590.
Sheehan, D. V. (1999). Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder. Journal of Clinical Psychiatry, 60, 23–28.
Silverman, W. K., & Eisen, A. R. (1992). Age differences in the reliability of parent and child reports of child anxious symptomatology using a structured interview. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 117–124.
Simon, N. M., Blacker, D., Korbly, N. B., et al. (2002). Hypothyroidism and hyperthyroidism in anxiety disorders revisited: New data and literature review. Journal of Affective Disorders, 69, 209–217.
Slade, T., & Andrews, G. (2001). DSM-IV and ICD-10 generalized anxiety disorder. Social Psychiatry and Psychiatric Epidemiology, 36, 45–51.
Spitzer, R. L., Kroenke, K., Williams, J. B. W., et al. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166, 1092–1097.
Stanley, M. A., Beck, J. G., Novy, D. M., et al. (2003). Cognitive-behavioral treatment of late-life generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 71, 309–319.
Stefan, S., Cristea, I. A., Szentagotai Tatar, A., et al. (2019). Cognitive-behavioral therapy (CBT) for generalized anxiety disorder: Contrasting various CBT approaches in a randomized clinical trial. Journal of Clinical Psychology, 75, 1188–1202.
Steketee, G., & Barlow, D. H. (2002). Obsessive–compulsive disorder. In D. H. Barlow (Ed.), Anxiety and its disorders (2nd ed.). Guilford Press.
Strawn, J. R., Prakash, A., Zhang, Q., et al. (2015). A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 54, 283–293.
Strawn, J. R., Geracioti, L., Rajdev, N., et al. (2018). Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: An evidence-based treatment review. Expert Opinion on Pharmacotherapy, 19, 1057–1070.
Sykes, M. A., Blanchard, E. B., Lackner, J., et al. (2003). Psychopathology in irritable bowel syndrome: Support for a physiological model. Journal of Behavioral Medicine, 26, 361–372.
Szkodny, L. E., Newman, M. G., & Goldfried, M. R. (2014). Clinical experiences in conducting empirically supported treatments for generalized anxiety disorder. Behavior Therapy, 45, 7–20.
Tallis, F., Eysenck, M. W., & Mathews, A. (1992). A questionnaire for the measurement of nonpathological worry. Personality and Individual Differences, 13, 161–168.
Taylor, S. E., & Brown, J. D. (1994). Positive illusions and well-being revisited: Separating fact from fiction. Psychological Bulletin, 116, 21–27.
Taylor, S. E., Kemeny, M. E., Reed, G. M., et al. (2000). Psychological resources, positive illusions, and health. The American Psychologist, 55, 99–109.
Thayer, J. F., Friedman, B. H., & Borkovec, T. D. (1996). Autonomic characteristics of generalized anxiety disorder. Biological Psychiatry, 39, 255–266.
Tiihonen, J., Kuikka, J., Rasanen, P., et al. (1997). Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: A fractal analysis. Molecular Psychiatry, 2, 463–471.
Tolin, D. F., Wootton, B. M., Bowe, W., Bragdon, L. B., Davis, E. C., Gilliam, C. M., & Worden, B. (2013). Diagnostic interview for anxiety, mood, and OCD and related disorders (DIAMOND). Hartford, CT: Institute of Living/Hartford HealthCare Corporation.
Tolin, D. F., Gilliam, C., Wootton, B. M., et al. (2018). Psychometric properties of a structured diagnostic interview for DSM-5 anxiety, mood, and obsessive-compulsive and related disorders. Assessment, 25, 3–13.
Toner, B. B., Segal, Z. V., Emmott, S. D., et al. (2000). Cognitive-Behavioral treatment of irritable bowel syndrome: The brain–gut connection. Guilford Press.
Treanor, M., Erisman, S. M., Salters-Pedneault, K., et al. (2011). Acceptance-based behavioral therapy for GAD: Effects on outcomes from three theoretical models. Depression and Anxiety, 28, 127–136.
Tully, P. J., Cosh, S. M., & Baune, B. T. (2013). A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease. Psychology, Health & Medicine, 18, 627–644.
Turner, S. M., Beidel, D. C., & Stanley, M. A. (1992). Are obsessional thoughts and worry different cognitive phenomena? Clinical and Psychology Review, 12, 257–270.
Tyrer, P., Tyrer, H., Yang, M., & Guo, B. (2016). Long-term impact of temporary and persistent personality disorder on anxiety and depressive disorders. Personality and Mental Health, 10, 76–83.
van der Heiden, C., Muris, P., & van der Molen, H. T. (2012). Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder. Behaviour Research and Therapy, 50, 100–109.
Vargas, S. M., Cabassa, L. J., Nicasio, A., et al. (2015). Toward a cultural adaptation of pharmacotherapy: Latino views of depression and antidepressant therapy. Transcultural Psychiatry, 52, 244–273.
Vesga-López, O., Schneier, F. R., Wang, S., et al. (2008). Gender differences in generalized anxiety disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Clinical Psychiatry, 69, 1606–1616.
Weinberg, A., Kotov, R., & Proudfit, G. H. (2015). Neural indicators of error processing in generalized anxiety disorder, obsessive-compulsive disorder, and major depressive disorder. Journal of Abnormal Psychology, 124(1), 172.
Weisberg, R. B., Brown, T. A., & Wincze, et al. (2001). Causal attributions and male sexual arousal: The impact of attributions for a bogus erectile difficulty on sexual arousal, cognitions, and affect. Journal of Abnormal Psychology, 110, 324–334.
Wells, A. (1994). A multi-dimensional measure of worry: Development and preliminary validation of the anxious thoughts inventory. Anxiety, Stress, and Coping, 6, 289–299.
Wells, A. (2002). GAD, meta-cognition, and mindfulness: An information processing analysis. Clinical Psychology: Science and Practice, 9, 95–100.
Wisocki, P. A. (1988). Worry as a phenomenon relevant to the elderly. Behavior Therapy, 19, 369–379.
Wittchen, H. U., Zhao, S., Kessler, R. C., et al. (1994). DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Archives of General Psychiatry, 51, 355–364.
World Health Organization. (1994). International classification of diseases for mortality and morbidity statistics (10th Revision). World Health Organization.
World Health Organization. (2018). International classification of diseases for mortality and morbidity statistics (11th Revision). World Health Organization.
Wu, J. C., Buchsbaum, M. S., Hershey, T. G., et al. (1991). PET in generalized anxiety disorder. Biological Psychiatry, 29, 1181–1199.
Yassa, M. A., Hazlett, R. L., Stark, C. E. L., et al. (2012). Functional MRI of the amygdala and bed nucleus of the stria terminalis during conditions of uncertainty in generalized anxiety disorder. Journal of Psychiatric Research, 46, 1045–1052.
Yonkers, K. A., Bruce, S. E., Dyck, I. R., et al. (2003). Chronicity, relapse, and illness – Course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow-up. Depression and Anxiety, 17, 173–179.
Zhang, Y., Young, D., Lee, S., et al. (2002). Chinese Taoist cognitive psychotherapy in the treatment of generalized anxiety disorder in contemporary China. Transcultural Psychology, 39, 115–129.
Zimmerman, M., & Chelminski, I. (2003). Generalized anxiety disorder in patients with major depression: Is DSM-IV’s hierarchy correct? American Journal of Psychiatry, 160, 504–512.
Zinbarg, R. E., Mineka, S., Bobova, L., et al. (2016). Testing a hierarchical model of neuroticism and its cognitive facets: Latent structure and prospective prediction of first onsets of anxiety and unipolar mood disorders during 3 years in late adolescence. Clinical Psychological Science, 4, 805–824.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Rosellini, A.J., Brown, T.A. (2023). Anxiety and Fear-Related Disorders: Generalized Anxiety Disorder. In: Tasman, A., et al. Tasman’s Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-42825-9_74-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-42825-9_74-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42825-9
Online ISBN: 978-3-030-42825-9
eBook Packages: Springer Reference MedicineReference Module Medicine